Covered recipient · General Payments record
BENJAMIN COLLIE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2024
$1,535.31
- Reported across 96 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $303.93 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $139.62 | 8 |
| ABBVIE INC. | $88.82 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $38.60 | 2 |
| Mylan Specialty L.P. | $19.04 | 1 |
| Acerta Pharma LLC | $17.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.18 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491169 | CMS |
| ABBVIE INC. | $16.60 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491171 | CMS |
| ABBVIE INC. | $15.20 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491173 | CMS |
| ABBVIE INC. | $13.29 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491175 | CMS |
| ABBVIE INC. | $16.55 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103491177 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.85 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105759619 | CMS |
| Mylan Specialty L.P. | $19.04 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147321720 | CMS |
| Novartis Pharmaceuticals Corporation | $22.24 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086753177 | CMS |
| Novartis Pharmaceuticals Corporation | $16.36 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086753179 | CMS |
| Novo Nordisk Inc | $20.34 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096751728 | CMS |
| Novo Nordisk Inc | $18.96 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096748935 | CMS |
| Novo Nordisk Inc | $14.43 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096847476 | CMS |
| Novo Nordisk Inc | $16.84 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097158779 | CMS |
| Novo Nordisk Inc | $11.40 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096936435 | CMS |
| Novo Nordisk Inc | $19.48 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097667431 | CMS |
| Novo Nordisk Inc | $13.80 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097021656 | CMS |
| Novo Nordisk Inc | $24.37 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097596402 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.